Related Experiment Videos
Bacterial resistance to beta-lactam antibiotics
1Department of Pharmacy Practice M/C 886, University of Illinois at Chicago 60612, USA.
Summary
Antibiotic resistance, driven by antimicrobial use, hinders infectious disease eradication. Beta-lactamase inactivation is a key bacterial resistance mechanism, necessitating new strategies to combat resistant organisms.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- The emergence of antibiotic-resistant organisms is a significant barrier to eradicating infectious diseases.
- Widespread antimicrobial use in humans and animals drives the selection of resistant bacterial strains.
- Beta-lactam antibiotics are commonly prescribed, with beta-lactamase inactivation being a primary resistance mechanism.
Purpose of the Study:
- To review the historical development of antibiotic resistance.
- To discuss mechanisms of resistance, focusing on beta-lactamases.
- To explore the clinical relevance and strategies for overcoming antibiotic resistance.
Main Methods:
- Literature review of historical development of antibiotic resistance.
- Analysis of resistance mechanisms, including beta-lactamase classification.
- Examination of clinical impact and therapeutic approaches.
Main Results:
- Antibiotic resistance has evolved significantly, impacting infectious disease control.
- Beta-lactamase enzymes are a major cause of resistance to beta-lactam antibiotics.
- Therapeutic failures due to resistance lead to increased healthcare costs and adverse patient outcomes.
Conclusions:
- New strategies are crucial to prevent the spread of antibiotic-resistant organisms.
- Limiting future resistance requires careful antimicrobial stewardship.
- Addressing beta-lactamase-mediated resistance is vital for effective treatment.